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Summary
Background.  —  Guidelines  emphasize  the  implementation  of  local  networks  with  prehospitals  to  improve  the  management  of  patients  with  ST-segment  eleva-Guidelines; emergency  medical  system
ST-segment  elevation
myocardial  infarction
tion myocardial  infarction  (STEMI);  they  also  deﬁne  the  choice  of  reperfusion  strategies  and
adjunctive  treatments.
Aim.  —  To  assess  the  compliance  of  STEMI  emergency  care  with  current  French  guidelines  in  a
large area  of  France  and  to  identify  predictors  of  compliance  with  guidelines.
Abbreviations: cath-lab, catheterization laboratory; CI, conﬁdence interval; CICU, cardiology intensive care unit; CRF, case report form;
MS, emergency medical system; FMC, ﬁrst medical contact; IQR, interquartile range; MICU, medical intensive care unit; OR, Odds ratio;
CI, percutaneous coronary intervention; STEMI, ST-segment elevation myocardial infarction; UFH, unfractionated heparin.
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Method.  —  The  RESCA+31  registry  was  a  2-year,  multicentre,  prospective,  multidisciplinary
study, including  512  consecutive  patients  with  STEMI  evolving  within  12  hours  managed  by  emer-
gency physicians  in  the  prehospital  system  or  emergency  department.  Data  were  recorded
during the  emergency  phase  and  after  admission  to  cardiology.
Results.  —  First  medical  contact  (FMC)  was  prehospital  emergency  care  for  80%  of  patients;
97% received  reperfusion  treatment  and  98%  were  admitted  to  a  cardiology  intensive  care  unit
(CICU) with  a  catheterization  laboratory.  The  mortality  rate  was  5%.  Guidelines  were  complied
with in  41%  of  patients  for  reperfusion  strategies,  in  47%  for  adjunctive  treatments  and  in
23% for  both.  The  only  factor  independently  associated  with  guideline  compliance  was  FMC  by
prehospital  emergency  system.  In  52%  of  cases,  emergency  physicians  underestimated  the  delay
between FMC  and  admission  to  a  CICU.
Conclusion.  —  Despite  the  implementation  of  a  network,  compliance  with  guidelines  for  reper-
fusion strategies  and  adjunctive  treatments  was  insufﬁcient  in  our  area.  However,  very  few
patients  did  not  receive  reperfusion  therapy  and  the  mortality  rate  was  low.  Efforts  should  be
made to  improve  the  estimation  of  delay  before  primary  percutaneous  coronary  intervention.
© 2012  Elsevier  Masson  SAS.  All  rights  reserved.
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Résumé
Contexte.  —  Les  recommandations  insistent  pour  développer  des  réseaux  locaux  avec  les  sys-
tèmes préhospitaliers  pour  améliorer  la  prise  en  charge  des  patients  avec  un  infarctus  du
myocarde avec  sus-décalage  du  segment  ST  (IDM  ST+).  Elles  déﬁnissent  le  choix  des  stratégies
de reperfusion  et  des  traitements  adjuvants.
Objectif.  —  Évaluer  le  suivi  des  recommandations  franc¸aises  dans  un  département  pour  la  prise
en charge  en  urgences  des  IDM  ST+  et  identiﬁer  les  facteurs  prédictifs  de  suivi  des  recomman-
dations.
Méthodes.  — Le  registre  RESCA+31  est  une  étude  multicentrique,  multidisciplinaire  menée  pen-
dant deux  ans  et  incluant  512  patients  avec  un  IDM  ST+  évoluant  depuis  moins  de  12  heures  et  pris
en charge  par  des  urgentistes  préhospitaliers  ou  des  urgences.  Les  données  ont  été  recueillies
pendant  la  phase  d’urgence  et  après  l’admission  en  cardiologie.
Résultats.  — Le  premier  contact  médical  (PCM)  était  préhospitalier  pour  80  %  des  patients,  97  %
recevaient  un  traitement  de  reperfusion  et  98  %  étaient  admis  en  cardiologie  intervention-
nelle (CI).  La  mortalité  était  de  5  %.  Les  stratégies  de  reperfusion  étaient  mises  en  œuvre
en accord  avec  les  recommandations  pour  41  %  des  patients,  les  traitements  adjuvants  pour
47 %  et  les  deux  pour  21  %.  Le  seul  facteur  indépendant  de  suivi  des  recommandations  était
le PCM  par  le  système  préhospitalier.  Le  délai  PCM  admission  en  CI  était  sous-estimé  dans
52 %  des  cas.
Conclusion.  —  Malgré  le  développement  de  réseaux,  le  suivi  des  recommandations  pour  le  choix
des stratégies  de  reperfusion  et  les  traitements  adjuvants  a  été  insufﬁsant  dans  notre  départe-
ment. Toutefois,  très  peu  de  patients  n’ont  pas  bénéﬁcié  d’un  traitement  de  reperfusion  et  la
mortalité a  été  faible.  Des  efforts  doivent  être  faits  pour  estimer  les  délais  permettant  une
angioplastie  primaire.
© 2012  Elsevier  Masson  SAS.  Tous  droits  réservés.
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European  and  American  societies  of  cardiology  and  emer-
gency  care  have  deﬁned  recommendations  for  the  manage-
ment  of  ST-segment  elevation  myocardial  infarction  (STEMI)
[1,2]. Delay  in  receipt  of  reperfusion  therapy  strongly  corre-
lates  with  mortality,  regardless  of  the  reperfusion  strategy
chosen—thrombolysis  or  primary  percutaneous  coronary
intervention  (PCI)  [3,4]. The  guidelines  therefore  empha-
size  the  implementation  of  an  emergency  medical  system
(EMS)  to  reduce  delay  to  reperfusion.  In  this  network,  the
prehospital  organization  has  a  key  role  in  the  initial  diagno-
sis,  risk  stratiﬁcation  and  reperfusion  treatment  of  patients
with  STEMI  [1,2]. In  Europe,  a  statement  from  the  Euro-
pean  Society  of  Cardiology  Working  Group  on  Acute  Cardiac
a
[
eare emphasized  that  guidelines  and  recommendations
hould  be  translated,  taking  into  consideration  the  diversity
f  healthcare  systems  in  Europe,  and  that  their  implemen-
ation  should  be  adapted  to,  and  evaluated  in,  local  and
ational  circumstances  [5].  In  France  in  2007,  recommenda-
ions  were  developed  by  the  French  Societies  of  Emergency
nd  Cardiology,  under  the  auspices  of  the  Haute  Autorité
e  santé  (Health  Authority)  [6],  for  the  emergency  care  of
TEMI  before  care  by  the  cardiology  team.  The  treatment
elays,  reperfusion  strategies  and  adjunctive  treatments
ecommended  were  speciﬁc  to  the  emergency  phase.The  French  emergency  healthcare  system  beneﬁts  from
 high  level  of  medicalization  at  all  levels  of  management
7—9].  Public  health  campaigns  advocate  telephoning  an
mergency  medical  dispatch  centre  when  someone  presents
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ith  acute  chest  pain.  After  assessing  for  the  probability  of
cute  coronary  syndrome,  the  emergency  physician  in  the
mergency  centre  can  dispatch  a  medical  intensive  care  unit
MICU)  with  a  physician  on  board  if  a  myocardial  infarction  is
uspected.  If  a  diagnosis  of  STEMI  is  conﬁrmed,  treatment  is
nitiated  immediately  and  the  patient  is  usually  transferred
o  a  cardiology  intensive  care  unit  (CICU)  with  a  catheter-
zation  laboratory  (cath-lab).  However,  some  patients  fall
utside  of  this  system  and  arrive  directly  at  an  emergency
epartment.  In  this  case,  the  emergency  physicians  rapidly
ransfer  the  patient  to  a  CICU  with  a  cath-lab  after  beginning
eperfusion  treatment.  Collaboration  between  cardiologists
nd  emergency  physicians  is  very  important  in  this  system
nd  strategies  are  planned  jointly.  One  step  of  the  recom-
endation  concerns  the  assessment  of  quality  of  care  and
ompliance  with  guidelines.
The  aim  of  this  study  was  to  assess  the  compliance  of
TEMI  emergency  care  with  current  French  guidelines  in  a
arge  area  of  France.  The  secondary  objective  was  to  iden-
ify  predictors  of  guideline  compliance.
ethods
tudy design and setting
he  RESCA+31  registry  was  a  multicentre,  prospective,
ultidisciplinary  study  carried  out  between  January  2008
nd  January  2010  in  a  6309  km2 area  of  France—Haute
aronne—which  has  1,046,532  habitants.  In  this  area,  one
niversity  hospital,  one  emergency  medical  dispatch  cen-
re,  two  MICUs,  eight  emergency  departments  and  ﬁve  CICUs
each  with  a  cath-lab)  in  public  or  private  hospitals  are
perational;  all  participated  in  the  RESCA+31  registry.  All
ICU  cath-labs  had  a  high  volume  of  primary  PCI  procedures
10].  The  study  was  conducted  by  the  Regional  Observa-
ory  of  Emergency  Medicine  in  Midi-Pyrénées,  in  accordance
ith  the  principles  outlined  in  the  Declaration  of  Helsinki.
atients  were  informed  of  study  participation;  as  this  was
n  observational  study,  prior  written  consent  was  not  nec-
ssary.
election of patients
atients  with  STEMI  managed  by  emergency  physicians  in
he  MICU  or  emergency  department  were  included  prospec-
ively  by  the  treating  physician.  Patients  admitted  directly
o  a  cardiology  department  without  receiving  emergency
edical  care  were  not  enrolled  in  the  study.
Inclusion  criteria  were:  age  greater  or  equal  to  18  years;
hest  pain  for  more  than  20  minutes  and  less  than  12  hours;
nd  management  in  an  emergency  department  or  MICU.
ccording  to  the  guidelines,  ST-segment  elevation  on  a  17-
ead  electrocardiogram  was  deﬁned  as  more  than  0.1  mV  in
t  least  two  peripheral  leads  and  in  V4—V9,  V3R  and  V4R
recordial  leads  and  more  than  0.2  mV  in  V1—V3  precordial
eads.ata collection and processing
emographic,  clinical,  electrocardiographic  and  delay  data
ere  collected  prospectively  by  the  emergency  physician
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nd  recorded  on  a  case  report  form  (CRF).  The  treatments,
eperfusion  strategies  and  adjunctive  treatments  imple-
ented  by  the  emergency  physician  were  also  recorded,
long  with  data  on  whether  the  physician  intended  to
anage  the  patient  according  to  the  2007  guidelines  [6].
or  patients  admitted  to  a  CICU,  the  results  of  coronary
ngiography  and  angioplasty,  and  data  on  clinical  outcomes
ccurring  during  hospitalization  in  the  CICU  were  collected
y  the  treating  cardiologist.  A  research  assistant  checked
he  completeness  of  the  data  in  the  CRF.
ompliance with guidelines
he  guidelines  concerned  the  emergency  care  of  patients
ith  STEMI,  before  they  were  transferred  to  the  cardiology
eam.  An  algorithm  was  developed  to  choose  reperfusion
herapy  (primary  PCI  or  thrombolysis)  according  to  time  from
rst  medical  contact  (FMC)  to  balloon,  and  time  between
nset  of  symptoms  and  FMC.  Speciﬁcally,  an  emergency
ime  was  identiﬁed:  from  FMC  to  admission  to  the  CICU.
his  time  is  half  the  duration  of  the  FMC  to  balloon  time
i.e.  45  minutes).  After  admission  to  a  CICU  with  cath-
ab,  the  cardiologist  has  45  minutes  in  which  to  perform
rimary  PCI.
For  reperfusion  strategies,  patients  were  considered  to
ave  been  managed  according  to  the  guidelines  if  they
ollowed  the  algorithm  in  Fig.  1:  all  patients  received  reper-
usion  therapy;  patients  with  a  delay  from  FMC  to  CICU
dmission  of  less  than  45  minutes  and  a  time  since  onset
f  symptoms  of  less  than  3  hours  could  receive  thrombol-
sis  or  have  primary  PCI;  patients  with  a  time  from  FMC
o  CICU  admission  of  less  than  45  minutes  and  a time  since
nset  of  symptoms  of  more  than  3  hours  should  have  pri-
ary  PCI;  patients  with  a  time  from  FMC  to  CICU  admission
f  more  than  45  minutes  should  receive  thrombolytic  treat-
ent,  unless  contraindicated.
For  adjunctive  treatments,  the  choice  depends  on  the
eperfusion  strategy  and  the  patient’s  age  (Fig.  2):  all
atients  received  aspirin;  patients  who  had  undergone  pri-
ary  PCI  and  were  less  than  75  years  of  age  received
lopidogrel  300  mg  or  prasugrel  60  mg  and  an  intravenous
nfusion  of  unfractionated  heparin  (UFH)  60  IU/kg  intra-
enously;  patients  who  had  a  primary  PCI  and  were
ore  than  75  years  received  clopidogrel  75  mg  or  pra-
ugrel  60  mg  and  a  intravenous  infusion  of  UFH  of
0  IU/kg  intravenously;  patients  treated  with  a  throm-
olytic  agent  and  who  were  less  than  75  years  received
lopidogrel  300  mg,  an  intravenous  bolus  of  enoxaparin
0  mg  and  enoxaparin  1  mg/kg  subcutaneously;  patients
reated  with  a  thrombolytic  agent  and  age  more  than
5  years  received  clopidogrel  75  mg  and  UFH  60  IU/kg
ntravenously.
Patients  were  considered  to  have  been  managed  accord-
ng  to  the  guidelines  for  reperfusion  strategies  and
djunctive  treatments  if  they  fulﬁlled  both  conditions
escribed  above.
rimary data analysistatistical  analyses  were  conducted  using  STATA10  soft-
are  (StataCorp  LP,  College  Station,  TX,  USA).  Statistics  are
eported  as  means  with  standard  deviations,  and  medians
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sFigure 1. Reperfusion strategies. Cath-lab: catheterization labor
pPCI: primary percutaneous coronary intervention; STEMI: ST-segme
with  interquartile  ranges  (IQRs)  for  delays.  Means  were  com-
pared  using  Student’s  t  test  for  normally  distributed  data
or  the  non-parametric  two-sample  Mann-Whitney  rank  sum
test  for  data  not  ﬁtting  the  assumption  of  parametric  test-
ing.  Percentages  were  compared  using  Pearson’s  Chi-square
test  and  Fisher’s  exact  test.
Univariate  analyses  were  performed  to  identify  factors
associated  with  guideline  compliance  for  reperfusion  ther-
apies,  adjunctive  treatments  or  both.  We  introduced  all
variables  with  a  P-value  <  0.20  in  the  univariate  analyses  into
a  stepwise  multivariable  logistic  regression  analysis.  Odds
ratios  (ORs)  were  reported  with  95%  conﬁdence  intervals
(CIs).
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Figure 2. Adjunctive treatments. IU: international unit; i.v.: intraven
UFH: unfractionated heparin; Yr: year.; CICU: cardiology intensive care unit; FMC: ﬁrst medical contact;
levation myocardial infarction; THR: thrombolysis.
esults
haracteristics of the study population
uring  the  2  years  of  recruitment,  512  consecutive  patients
ith  a  ﬁnal  diagnosis  of  STEMI  were  included  in  our  study.
he  FMC  was  by  the  MICU  in  411  patients  (80%).  The
emographic,  clinical,  electrocardiographic  and  delay  in
are  management  data  are  reported  in  Table  1.  Reperfu-
ion  strategies  and  adjunctive  treatments  are  presented  in
able  2.  Reperfusion  strategies  were  performed  for  97%  of
atients;  only  14  patients  failed  to  receive  some  form  of
eperfusion  therapy,  11  of  whom  were  elderly.  Thrombolytic
ous; PCI: percutaneous coronary intervention; SC: subcutaneous;
266  
Table  1  Baseline  characteristics.
Variable
Men 390  (76)
Age  (years)  62  ±  15
Age  ≤  75  years  136  (26)
Risk  factors
Diabetes 71  (14)
Hyperlipidaemia 174  (3)
Smoker 229  (45)
Hypertension 201  (39)
Family  history  of  CAD  93  (18)
More  than  one  risk  factor  449  (88)
Previous  CAD  87  (17)
Killip  class  ≤  1  382  (82)
Anterior  site  STEMI  199  (39)
MICU  FMC  411  (80)
Period  of  initial  management  8—20  hours  295  (60)
Delays  (minutes)
Time  since  symptom  onset  92  (82—183)
Time  since  symptom
onset  <  180  minutes
349  (74)
FMC  to  arrival  in  cardiology  84  (59—129)
FMC  to  arrival  in
cardiology  <  45  minutes
48  (11)
FMC  to  balloon  127  (92—190)
FMC  to  balloon  <  90  minutes  50  (21)
FMC  to  needle  20  (10—24)
Data are number (%), mean ± standard deviation or median
(interquartile range). CAD: coronary artery disease; FMC: ﬁrst
medical contact; MICU: medical intensive care unit; PCI: per-
cutaneous coronary intervention; STEMI: ST-segment elevation
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herapy  was  contraindicated  in  51  patients.  Primary  PCI  was
he  most  common  reperfusion  strategy  used  (68%),  partic-
larly  in  elderly  patients  (81%).  The  FMC  to  balloon  time
as  less  than  90  minutes  for  21%  of  patients  and  less  than
20  minutes  for  44%  of  patients.
Table  2  Reperfusion  strategies  and  adjunctive
treatments.
Variables  n  (%)
Reperfusion  strategies  495  (97)
Thrombolysis  alone  1  (0.2)
Thrombolysis  plus  PCI  150  (29)
Primary  PCI  344  (68)
Unknown  3  (0.6)
Adjunctive  treatments
Aspirin  plus  clopidogrel  417  (84)
GP  IIb/IIIa  inhibitors  71  (14)
UFH/HBPM  454  (90)
Morphine  189  (37)
Beta-blockers  4  (0.8)
GP: glycoprotein; HBPM: home blood pressure monitoring; PCI:
percutaneous coronary intervention; UFH: unfractionated
heparin.
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Patients  were  admitted  to  a  CICU  with  a  cath-lab  in
8%  of  cases;  359  of  these  (76.7%)  were  admitted  directly
o  the  cath-lab.  Among  patients  treated  with  primary  PCI,
71  (82.9%)  were  admitted  directly  to  the  cath-lab.  Among
atients  treated  by  thrombolysis,  88  (62.4%)  were  admitted
irectly  to  the  cath-lab.
The  median  delay  between  cardiology  admission  to  bal-
oon  inﬂation  was  40  (IQR  29—61)  minutes  for  patients
reated  by  primary  PCI  and  144  (IQR  45—1479)  minutes  for
atients  treated  by  thrombolysis.  The  FMC  to  balloon  time
as  shorter  for  patients  transferred  directly  to  the  cath-
ab  (117  minutes,  IQR  90—170)  than  for  patients  admitted
nitially  to  a  CICU  (224  minutes,  IQR  174—460).
The  overall  hospital  mortality  rate  was  5%,  and  was  4.6%
or  patients  treated  by  thrombolysis  plus  PCI  and  3.5%  for
atients  treated  by  primary  PCI  (P  =  0.5).
ompliance with guidelines
e  evaluated  compliance  with  guidelines  for  reperfusion
trategies  and  adjunctive  treatments  separately,  as  well  as
ompliance  with  guidelines  for  both  management  practices.
For  reperfusion  strategies,  41%  of  patients  were  managed
ccording  to  the  guidelines.  In  the  univariate  analysis,  fac-
ors  associated  with  guideline  compliance  for  reperfusion
trategies  were:  age  less  than  75  years,  FMC  and  period  of
nclusion  (Table  3).  In  the  multivariable  analysis,  sex,  age,
MC,  STEMI  size  and  period  of  inclusion  were  included  in  the
odel.  The  factors  independently  associated  with  guideline
ompliance  for  reperfusion  strategies  were:  age  less  than
5  years  (OR  1.9,  95%  CI  1.2—2.9);  FMC  by  MICU  (OR  3.2,
5%  CI  1.9—5.3);  and  ﬁrst  year  of  inclusion  (OR  1.9,  95%  CI
.3—2.8).
For  adjunctive  treatments,  47%  of  patients  were  man-
ged  according  to  the  guidelines.  Factors  associated  with
uideline  compliance  for  adjunctive  treatments  in  the  uni-
ariate  analysis  are  reported  in  Table  3.  In  the  multivariable
nalysis,  the  variables  independently  associated  with  lack  of
uideline  compliance  for  adjunctive  treatments  were:  age
ess  than  75  years  (OR  0.5,  95%  CI  0.3—0.8);  primary  PCI  (OR
.4,  95%  CI  0.3—0.6);  and  more  than  one  cardiovascular  risk
actor  (OR  0.5,  95%  CI  0.3—0.97).
For  reperfusion  strategies  and  adjunctive  treatments
ogether,  23%  of  patients  were  managed  according  to  the
uidelines.  Factors  associated  with  guideline  compliance  for
oth  reperfusion  strategies  and  adjunctive  treatments  in
he  univariate  analysis  are  reported  Table  3.  In  the  multi-
ariable  analysis,  sex,  age,  FMC,  STEMI  location,  period  of
nclusion  and  cardiovascular  risk  factors  were  included  in
he  model.  The  only  factor  independently  associated  with
uideline  compliance  for  both  was  FMC  by  MICU  (OR  2.9,
5%  CI  1.5—5.7).
For  each  patient,  the  emergency  physician  was  asked
heir  opinion  regarding  compliance  with  the  guidelines;  half
f  the  physicians  did  not  answer  the  question.  Among  those
hat  did  answer,  89%  thought  that  the  guidelines  had  been
ollowed.  When  asked  to  estimate  the  time  between  FMC
nd  admission  to  cardiology,  physicians  estimated  it  as  being
ess  than  45  minutes  for  52%  of  patients,  although  40%  did
ot  provide  an  answer.
The  mortality  rate  was  lower  for  patients  managed
ccording  to  the  guidelines  for  reperfusion  strategies  (2.4%,
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Table  3 Factors  associated  with  compliance  with  guidelines  for  reperfusion  strategies,  adjunctive  treatments  and  both  (univariate  analysis).
Factors Compliance  with  guidelines
for  reperfusion  strategies
Compliance  with  guidelines
for  adjunctive  treatments
Compliance  with  guidelines  for  both
n  (%) OR  (95%  CI) P n (%) OR  (95%  CI) P n (%) OR  (95%  CI) P
Sex
Women 44 (36)  Reference 0.2 63 (52)  Reference 0.23 23 (19)  Reference 0.19
Men 165 (43)  1.3  (0.9—2.0)  176 (45)  0.8  (0.5—1.2)  95 (25)  1.4  (0.8—2.3)
Age  (years)
>  75 41 (30) Reference <  0.005 76 (56)  Reference <  0.05 26 (19)  Reference 0.19
<  75 168 (45) 1.9  (1.2—2.9)  163 (44)  0.6  (0.4—0.9)  22 (25)  1.4  (0.9—2.3)
First  medical  contact
Emergency  department 22 (22)  Reference <  0.0001 42 (42)  Reference 0.23 11 (11)  Reference <  0.001
MICU 187 (46)  3.0  (1.8—5.1)  179 (48)  1.3  (0.8—2.0)  107 (26)  2.9  (1.5—5.7)
STEMI  location
Other 137 (44)  Reference 0.08 147 (47)  Reference 0.83 79 (25)  Reference 0.132
Anterior 72 (36)  0.7  (0.5—1.0)  92 (46)  1.0  (0.7—1.4)  39 (20)  0.7  (0.5—1.1)
Period  of  inclusion
Second  year 79 (33)  Reference <  0.0001 110 (46)  Reference 0.57 53 (22)  Reference 0.54
First  year 130 (48)  1.9  (1.3—2.8)  129 (48)  1.1  (0.8—1.6)  65 (24)  1.1  (0.8—1.7)
Cardiovascular  risk  factors
<  1 23 (45) Reference 0.62 31 (61)  Reference <  0.05 16 (31)  Reference 0.18
≥  1 185 (42) 0.9  (0.5—1.6)  203 (46)  0.5  (0.3—0.9)  102 (23)  0.5  (0.3—1.2)
Time  of  symptom  onset
08.00  to  20.00 87 (44)  Reference 0.58 94 (47)  Reference 0.95 54 (27)  Reference 0.16
20.00  to  08.00 122 (42)  0.9  (0.6—1.3)  139 (47)  1.0  (0.8—1.6)  64 (24)  0.7  (0.5—1.0)
Reperfusion  strategy
Thrombolysis 92 (61)  Reference <  0.0001
Primary  PCI 143 (42) 0.5  (0.3—0.7)
CI: conﬁdence interval; MICU: medical intensive care unit; OR: odds ratio; PCI: percutaneous coronary intervention; STEMI: ST-segment elevation myocardial infarction.
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 =  5)  compared  with  patients  not  managed  according  to  the
uidelines  (6.7%,  n  =  20;  P  <  0.05).  For  patients  who  received
eperfusion  treatment,  not  choosing  the  reperfusion  strat-
gy  recommended  by  the  guidelines  did  not  signiﬁcantly
ncrease  patient  mortality  (4.9%  [n  =  14]  vs  2.4%  [n  =  5];
 =  0.15)  although  the  trend  was  in  favour  of  compliance  with
uidelines.  We  found  no  difference  in  mortality  rates  accord-
ng  to  compliance  with  guidelines  for  adjuvant  treatment
4.8%  vs  5.0%;  P  =  0.91).
iscussion
ur  ﬁndings  show  that  compliance  with  guidelines  for  reper-
usion  strategies  or  adjunctive  treatments  was  insufﬁcient
nd  that  more  than  half  of  the  patients  were  not  managed
ccording  to  the  recommendations.  The  lack  of  compliance
ith  guidelines  for  reperfusion  strategies  increased  mortal-
ty,  particularly  for  patients  who  did  not  receive  any  form  of
eperfusion.
In  our  study,  the  guidelines  were  adjusted  to  be  appropri-
te  in  the  context  of  emergency  care,  and  the  delays  were
peciﬁc  to  care  prior  to  admission  to  a  cardiology  unit.  Cur-
ent  recommendations  emphasize  that  the  implementation
f  regional  protocols  is  required  to  adapt  to  constraints  at
he  local  level  [2].  These  results  underline  the  importance
f  both  promoting  and  implementing  a  regional  protocol  as
ell  as  the  need  to  monitor  its  effectiveness.
eneral implementation of guidelines for
mergency care of patients with STEMI
he  only  factor  associated  with  guideline  compliance  for
oth  reperfusion  strategies  and  adjunctive  treatments  in
ur  study  was  FMC  by  MICU.  In  France,  media  campaigns
ncourage  the  general  public  to  call  the  medical  dispatch
entre  with  a  unique  phone  number  if  they  develop  chest
ain  [7].  Thus,  most  patients  are  identiﬁed  over  the  tele-
hone  as  having  an  acute  coronary  syndrome  and  are
ubsequently  managed  by  the  MICU.  This  network  has  been
ffective  for  many  years,  and  the  number  of  patients  arriv-
ng  independently  at  emergency  departments  has  declined.
rench  registries  have  shown  that  the  management  of  these
atients  in  emergency  departments  was  frequently  delayed
nd  reperfusion  was  less  often  implemented  compared  with
are  in  the  MICU  [11]. Even  when  patients  were  not  managed
ccording  to  the  guidelines  regarding  choice  of  reperfu-
ion  strategy  and  adjunctive  treatment,  our  study  showed
emarkable  results  concerning  the  use  of  the  prehospi-
al  EMS.  Guidelines  emphasize  the  key  role  of  prehospital
are  [2,5], and  failure  to  use  the  EMS  increases  delays  in
reatment  and  mortality  rates  [12]. Most  countries  have
eveloped  prehospital  care  with  or  without  physicians  in  the
mbulance.  In  the  Vienna  registry,  60%  of  patients  were  man-
ged  by  prehospital  care  compared  with  80%  in  our  registry
13].
mplementation of guidelines for reperfusion
trategies
 lack  of  guideline  compliance  has  been  reported  only  in
tudies  regarding  reperfusion  strategies—mainly  the  absence
t
p
H
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f  reperfusion  therapy  [14—16]. Age,  sex  and  comorbidi-
ies  were  associated  with  failure  to  provide  reperfusion.  In
ur  study,  most  elderly  patients  (92%)  beneﬁted  from  reper-
usion  strategies  but  the  choice  of  reperfusion  tended  to
avour  primary  PCI  and  was  not  chosen  in  accordance  with
he  guideline  algorithm.
Fewer  than  half  of  the  patients  were  managed  in  compli-
nce  with  the  guidelines.  Despite  this,  most  physicians
hought  that  they  had  managed  their  patients  according
o  the  recommendations.  Physicians  also  underestimated
he  delay  between  FMC  and  admission  to  cardiology.  Most
atients  were  managed  not  far  from  a  CICU  with  a  cath-lab,
ut  the  constraints  encountered  by  the  MICU  or  trafﬁc  on  the
oad  often  did  not  allow  for  an  accurate  estimation  of  time.
he  time  permitted  for  primary  PCI  was  very  short—the  car-
iologist  had  45  minutes  in  which  to  perform  the  angioplasty
nd  achieve  balloon  inﬂation.  In  our  registry,  cardiologists
eeded  45  minutes  in  which  to  perform  the  angioplasty,  and
t  the  time  our  study  was  conducted  we  could  not  increase
he  ﬁrst  delay.  Indeed,  the  latest  guidelines  recommend  a
aximum  delay  of  120  minutes  between  FMC  and  balloon
nﬂation,  permitting  an  increased  ﬁrst  delay  [2].  The  net-
ork  set  up  in  our  area  allowed,  however,  for  an  increase
n  the  proportion  of  patients  receiving  reperfusion  strate-
ies.  In  a  previous  study  carried  out  from  2001  to  2003,
1%  of  patients  did  receive  reperfusion  therapy  [17], and
his  proportion  decreased  to  3%  for  patients  managed  by
mergency  physicians.  In  the  European  registries,  25—35%
f  patients  did  not  receive  reperfusion  therapy  [9].  In  the
ienna  registry,  the  proportion  of  patients  receiving  any
eperfusion  increased  to  87%  [13]. In  the  UK,  18%  of  patients
id  not  receive  reperfusion  [18]. In  France,  the  FAST-MI  reg-
stry  reported  a  lack  of  reperfusion  for  30%  of  patients  and
or  18%  of  patients  who  called  the  Service  d’aide  médi-
ale  urgente  (Samu;  emergency  services)  initially  [7,19].
ur  rates  of  reperfusion  are  therefore  considerably  higher
han  those  reported  from  other  areas  in  Europe  and  are  the
onsequence  of  a  network  developed  between  emergency
hysicians  and  cardiologists  [20]. All  of  the  protocols  had
een  approved  by  the  emergency  team  involved  in  STEMI
are  in  our  area,  and  all  physicians  had  beneﬁtted  from
raining  to  diagnose  and  treat  STEMI.  A  direct  phone  number
s  available  for  emergency  physicians  to  call  a  ‘round-the-
lock’  cath-lab;  then,  all  patients  are  transported  directly
o  a  CICU  with  a  cath-lab  by  the  prehospital  EMS  (or  after
ransfer  if  patients  arrive  initially  at  an  emergency  depart-
ent),  with  or  without  receiving  prehospital  thrombolysis,
epending  on  whether  the  delays  are  sufﬁciently  short  not  to
reclude  primary  PCI.  Only  1%  of  our  patients  were  treated
y  thrombolysis  without  PCI,  showing  an  optimal  pharma-
oinvasive  strategy  [21—23].
Delays  in  our  study  were  therefore  short  for  FMC  to
eedle  compared  with  those  reported  in  other  European
ountries  [20]. In  contrast,  the  FMC  to  balloon  time  was  still
ong  (only  21%  of  patients  had  an  FMC  to  balloon  time  of  less
han  90  minutes  when  primary  PCI  was  performed)  and  the
ime  before  admission  to  cardiology  was  too  long.  Registries
ave  shown  that  this  time  goal  is  very  difﬁcult  to  achieve.  In
he  National  Registry  of  Myocardial  Infarction,  only  4.2%  of
rimary  PCIs  were  performed  within  90  minutes  of  FMC  [24].
owever,  in  the  Vienna  registry,  79.7%  of  patients  had  a  door-
o-balloon  time  of  less  than  90  minutes  in  the  case  of  direct
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transfer;  and  in  the  United  States,  the  implementation  of
prehospital  triage  allowed  an  electrocardiogram-to-balloon
time  of  less  than  90  minutes  to  be  achieved  for  68%  of
patients  [13,25].  Most  countries  in  Europe  have  an  FMC
to  balloon  time  of  about  120  minutes  and  only  half  of  our
patients  were  managed  according  to  this  delay  [20].
Implementation of guidelines for adjunctive
treatments
To  our  knowledge,  no  study  has  assessed  compliance  with
guidelines  regarding  adjunctive  emergency  treatments.  In
a  previous  study,  Schiele  et  al.  built  a  compliance  index
that  included  adjunctive  treatment  but  the  results  can-
not  be  extrapolated  to  our  study  in  the  emergency  area
[26].  In  contrast  with  reperfusion  strategies,  elderly  patients
were  more  likely  than  younger  patients  to  receive  guideline-
recommended  adjunctive  treatments.  This  could  be  because
emergency  physicians  take  greater  care  in  prescribing  treat-
ments  that  could  lead  to  bleeding  complications  when  caring
for  older  patients.  This  may  also  explain  the  choice  of
primary  PCI  rather  than  thrombolysis.  It  has  been  well
demonstrated  that  bleeding  complications  increase  the  mor-
tality  of  patients  and  that  age  is  a  strong  predictor  of  having
a  major  haemorrhage  [27]. The  overdosing  of  anticoagu-
lants  is  well  known  as  a  cause  of  bleeding  and  consequently
emergency  physicians  are  extremely  cautious  in  the  use  and
prescription  of  anticoagulants  [28].
Relationship between compliance with
guidelines and clinical outcomes
Lack  of  guideline  compliance  can  lead  to  an  increase  in
mortality  rates  [17,26].  Our  study  conﬁrmed  this  result,
particularly  for  patients  who  did  not  receive  reperfusion
treatment;  for  these  individuals,  the  trend  was  in  favour
of  compliance  with  guidelines  even  if  the  difference  was
not  signiﬁcant,  probably  explained  by  a  lack  of  statistical
power.  However,  the  result  of  our  network  was  a  low  hospi-
tal  mortality  rate  compared  with  the  mortality  rate  in  the
FAST-MI  registry  [19]. The  organization  of  a  regional  network
is  known  to  be  associated  with  a  reduction  in  mortality  rate
[29].  In  the  Vienna  registry,  the  mortality  rate  was  9.5%,  in
the  Bologna  study  it  was  12.3%,  and  in  the  Mayo  clinic  experi-
ence  it  was  5.7%  for  patients  treated  by  primary  PCI  and  3.1%
for  those  treated  by  thrombolysis  [29,30].  The  short  FMC
to  needle  time  and  the  pharmacoinvasive  strategy  explain
the  low  mortality  rate  for  patients  treated  by  ﬁbrinolysis
[22,31].
Study limitations
This  study  was  registry-based,  thus  no  causal  inference  can
be  made  from  the  associations  observed  between  the  covari-
ates  and  guideline  compliance.  Second,  we  only  included
patients  managed  by  the  emergency  team  as  the  FMC.  Also,
we  did  not  include  patients  admitted  directly  to  the  cardiol-
ogy  unit.  In  a  previous  study,  these  patients  represented  20%
of  those  in  care.  We  did  not  include  these  patients  because
we  wanted  to  assess  the  emergency  network  according  to
the  speciﬁc  guidelines.269
Despite  being  a  registry-based  study,  the  completeness
f  inclusion  was  high;  a  research  technician  regularly  veri-
ed  the  lack  of  missing  STEMIs  in  each  institution.  However,
e  may  have  missed  patients  who  used  private  emergency
acilities  rather  than  the  public  system.
onclusion
espite  implementation  across  the  network,  guideline
ompliance  was  insufﬁcient  in  our  area.  FMC  by  a  MICU  was
ssociated  with  compliance,  but  physician  underestimation
f  the  delay  between  FMC  and  admission  to  the  cardiology
nit  may  be  an  important  factor  associated  with  failure  to
omply  with  guidelines.  Nevertheless,  the  network  imple-
ented  in  our  area  jointly  by  emergency  physicians  and
ardiologists  allowed  improvement  in  the  implementation  of
eperfusion  strategies.  Thus,  the  mortality  of  patients  with
TEMI  was  low.  Efforts  should  therefore  be  made  to  improve
MC  to  balloon  time  in  the  case  of  primary  PCI.
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